These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21902599)

  • 1. Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing.
    Rohlena J; Dong LF; Kluckova K; Zobalova R; Goodwin J; Tilly D; Stursa J; Pecinova A; Philimonenko A; Hozak P; Banerjee J; Ledvina M; Sen CK; Houstek J; Coster MJ; Neuzil J
    Antioxid Redox Signal; 2011 Dec; 15(12):2923-35. PubMed ID: 21902599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis.
    Truksa J; Dong LF; Rohlena J; Stursa J; Vondrusova M; Goodwin J; Nguyen M; Kluckova K; Rychtarcikova Z; Lettlova S; Spacilova J; Stapelberg M; Zoratti M; Neuzil J
    Antioxid Redox Signal; 2015 Apr; 22(11):883-900. PubMed ID: 25578105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy.
    Kovarova J; Bajzikova M; Vondrusova M; Stursa J; Goodwin J; Nguyen M; Zobalova R; Pesdar EA; Truksa J; Tomasetti M; Dong LF; Neuzil J
    Redox Rep; 2014 Jan; 19(1):16-25. PubMed ID: 24225203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress.
    Dong LF; Swettenham E; Eliasson J; Wang XF; Gold M; Medunic Y; Stantic M; Low P; Prochazka L; Witting PK; Turanek J; Akporiaye ET; Ralph SJ; Neuzil J
    Cancer Res; 2007 Dec; 67(24):11906-13. PubMed ID: 18089821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer and antiangiogenic activity of surfactant-free nanoparticles based on self-assembled polymeric derivatives of vitamin E: structure-activity relationship.
    Palao-Suay R; Aguilar MR; Parra-Ruiz FJ; Fernández-Gutiérrez M; Parra J; Sánchez-Rodríguez C; Sanz-Fernández R; Rodrigáñez L; Román JS
    Biomacromolecules; 2015 May; 16(5):1566-81. PubMed ID: 25848887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II.
    Dong LF; Jameson VJ; Tilly D; Cerny J; Mahdavian E; Marín-Hernández A; Hernández-Esquivel L; Rodríguez-Enríquez S; Stursa J; Witting PK; Stantic B; Rohlena J; Truksa J; Kluckova K; Dyason JC; Ledvina M; Salvatore BA; Moreno-Sánchez R; Coster MJ; Ralph SJ; Smith RA; Neuzil J
    J Biol Chem; 2011 Feb; 286(5):3717-28. PubMed ID: 21059645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Tocopheryl Succinate-Based Polymeric Nanoparticles for the Treatment of Head and Neck Squamous Cell Carcinoma.
    Sánchez-Rodríguez C; Palao-Suay R; Rodrigáñez L; Aguilar MR; Martín-Saldaña S; San Román J; Sanz-Fernández R
    Biomolecules; 2018 Sep; 8(3):. PubMed ID: 30235821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy.
    Dong LF; Jameson VJ; Tilly D; Prochazka L; Rohlena J; Valis K; Truksa J; Zobalova R; Mahdavian E; Kluckova K; Stantic M; Stursa J; Freeman R; Witting PK; Norberg E; Goodwin J; Salvatore BA; Novotna J; Turanek J; Ledvina M; Hozak P; Zhivotovsky B; Coster MJ; Ralph SJ; Smith RA; Neuzil J
    Free Radic Biol Med; 2011 Jun; 50(11):1546-55. PubMed ID: 21402148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue.
    Rodríguez-Enríquez S; Hernández-Esquivel L; Marín-Hernández A; Dong LF; Akporiaye ET; Neuzil J; Ralph SJ; Moreno-Sánchez R
    Biochim Biophys Acta; 2012 Sep; 1817(9):1597-607. PubMed ID: 22627082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.
    Reddy VG; Reddy TS; Jadala C; Reddy MS; Sultana F; Akunuri R; Bhargava SK; Wlodkowic D; Srihari P; Kamal A
    Eur J Med Chem; 2019 Nov; 182():111609. PubMed ID: 31445229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Tocopheryl succinate stabilizes the structure of tumor vessels by inhibiting angiopoietin-2 expression.
    Hama S; Okamura Y; Kamei K; Nagao S; Hayashi M; Shizuka M; Fukuzawa K; Kogure K
    Biochem Biophys Res Commun; 2020 Jan; 521(4):947-951. PubMed ID: 31718795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing.
    Coutelle O; Hornig-Do HT; Witt A; Andree M; Schiffmann LM; Piekarek M; Brinkmann K; Seeger JM; Liwschitz M; Miwa S; Hallek M; Krönke M; Trifunovic A; Eming SA; Wiesner RJ; Hacker UT; Kashkar H
    EMBO Mol Med; 2014 May; 6(5):624-39. PubMed ID: 24648500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to α-tocopheryl succinate.
    Prochazka L; Koudelka S; Dong LF; Stursa J; Goodwin J; Neca J; Slavik J; Ciganek M; Masek J; Kluckova K; Nguyen M; Turanek J; Neuzil J
    Apoptosis; 2013 Mar; 18(3):286-99. PubMed ID: 23299931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Tocopheryloxyacetic acid is superior to α-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability.
    Dong LF; Grant G; Massa H; Zobalova R; Akporiaye E; Neuzil J
    Int J Cancer; 2012 Sep; 131(5):1052-8. PubMed ID: 22038845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alpha tocopheryl succinate (α-TOS) as a potential anticancer agent.
    Angulo-Molina A; Reyes-Leyva J; López-Malo A; Hernández J
    Nutr Cancer; 2014; 66(2):167-76. PubMed ID: 24364743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo.
    Chao WR; Amin K; Shi Y; Hobbs P; Tanabe M; Tanga M; Jong L; Collins N; Peters R; Laderoute K; Dinh D; Yean D; Hou C; Sato B; Alt C; Sambucetti L
    Angiogenesis; 2011 Mar; 14(1):1-16. PubMed ID: 21104121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance.
    Naito H; Wakabayashi T; Kidoya H; Muramatsu F; Takara K; Eino D; Yamane K; Iba T; Takakura N
    Cancer Res; 2016 Jun; 76(11):3200-10. PubMed ID: 27197162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.